Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00616
Species: Homo sapiens
Position : chr14:23871436-23872136
Year: 2021
Title: Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  33478249
Tissue: heart left ventricle
Tissue Ontology ID: UBERON:0002084
Cell Source: GM03348-derived human iPSC cardiomyocytes
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay
High Throughput Method: Promoter Capture Hi-C; H3K27ac ChIP-seq; ATAC-seq; H3K4me3 ChIP-seq; CTCF ChIP-seq; p300 ChIP-seq; cardiac TF ChIP-seq
Low Throughput Method: Dual-luciferase reporter assay of MYH7-C1-4 in iPSC-CMs and HL-1 cells
About Target Gene
Target gene : MYH7
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_00473 chr14:23870761-23871458 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00474 chr14:23870761-23871458 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00475 chr14:23871436-23872136 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00476 chr14:23871436-23872136 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00617 chr14:23871436-23872136 heart left ventricle cardiac muscle cell NA
Expression of Target Genes for the Enhancer